Back to rankings
Katzenell Dimant

Katzenell Dimant

More information

Israel

3

Healthcare and life sciences

Katzenell Dimant‘s healthcare and life sciences practice boasts experts in regulatory compliance, ethical codes of conduct, protocols, licensing, and data protection and privacy. The Herzliya-based team is also experienced in clinical trials, and interacting with clinical research organisations, hospitals, and academic institutions. Einat Katzenell, who ’brings a rare mix of technical excellence and commercial pragmatism’, co-leads the group alongside Ran Dimant, Neil Stowe and Eyal Sternberg.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency

Testimonials

Collated independently by Legal 500 research team.

  • ‘What stands out most is their ability to navigate disputes with clarity and precision, ensuring legal protections while always keeping the company’s operational needs in mind.’
  • ‘Their responsiveness, strategic thinking, and ability to coordinate across jurisdictions set them apart from other firms.’
  • ‘The partners and associates are consistently available, hands-on, and solution driven.’
  • ‘Ability to explain complex legal risks in clear, actionable terms that allows clients to make quick decisions in high-stakes environments.’
  • ‘Attention to detail and efficiency under time pressure.’
  • ‘Einat Katzenell brings a rare mix of technical excellence and commercial pragmatism.’

Key clients

  • Belkin Vision
  • Bio View
  • Unbox Ventures
  • Holon Institute of Technology
  • BIRAD Bar-Ilan Research & Development Company
  • Rendiatech
  • Nanomedic Technologies
  • G-Medical Innovations
  • Capital Point
  • Surgical KIS
  • ItaiAndBeyond
  • Partam High-Tech

Work highlights

Advised Belkin Vision on a $466m merger transaction with a subsidiary of pharmaceutical Company Alcon.
Successfully represented Bio View in an attempted hostile takeover attempt.
Advised Bluespine Technologies on its seed and Series A financing round, as well as its global commercial activities and engagement with strategic partners.
Practice head

Einat Katzenell; Ran Dimant; Neil Stowe; Eyal Sternberg